Cellular and Humoral Immunity Notes PDF

Cellular and Humoral Immunity Notes PDF

Humoral immunity and Cellular immunity are two kinds of adaptive immunity during which a particular immunologic response is produced for a specific pathogen. In humoral immunity, antibodies are produced by the plasma T-cells. While in the case of cell-mediated immunity, T cells induce the apoptosis of the infected cells. Humoral immunity destroys the extracellular pathogens while cell-mediated immunity destroys the intracellular pathogens.

(more…)
Continue ReadingCellular and Humoral Immunity Notes PDF

Immunoglobulins Notes PDF

Immunoglobulins Notes PDF

Antibodies or immunoglobulins are a class of disease-fighting proteins produced by B cells found in the lymphatic system or bone marrow. Antibodies are produced to bind a specific antigen that has stimulated the immune system. Their selectivity and tunability to recognize and bind an almost infinite range of large- and small molecule substrates is what makes antibodies so important to the immune system.

(more…)
Continue ReadingImmunoglobulins Notes PDF

Post-Approval Changes to NDA and ANDA ppt pdf

Post-Approval Changes to NDA and ANDA ppt pdf

Holders who intend to make post-approval changes to NDA and ANDA should follow in accordance with section 506A of the Federal Food, Drug, and  Cosmetic Act. An applicant must provide Specific information to assess the effect of the change on the identity, strength,  quality, purity, or potency of a drug product as these factors may relate to the safety or effectiveness of the drug.

(more…)
Continue ReadingPost-Approval Changes to NDA and ANDA ppt pdf

Abbreviated New Drug Application (ANDA)

Abbreviated New Drug Application (ANDA)

Abbreviated New Drug Application (ANDA) is an application for a U.S. generic drug approval (for an existing licensed approved drug). The ANDA is submitted to the office of Generic drugs, US. After a review of the documents, USFDA gives approval as generic drugs.

After approval, an applicant may manufacture and market the generic drug product to the US market. A generic drug product is one that is similar to branded drug product in dosage form, strength, and route of administration, quality, performance characteristics, and intended use.

(more…)
Continue ReadingAbbreviated New Drug Application (ANDA)

In-Process Quality Control (IPQC) Notes

usually performed within the production area. The performance of such in-process controls should not have any negative effect on the quality of the product or another product. In-process inspection and testing should be performed by monitoring the process or by actual sample analysis at defined locations and times. The results should conform to established process parameters or acceptable tolerances.

Continue ReadingIn-Process Quality Control (IPQC) Notes

Complaints and Recalls in Pharmaceuticals

All complaints and other information concerning potentially defective products must be kept and reviewed according to written procedures. In order to provide for all contingencies, a system shall be designed to recall, if necessary, promptly and effectively products known or suspected to be defective from the market.

Continue ReadingComplaints and Recalls in Pharmaceuticals

Self Inspection

Self-inspection is basically a method of objective overall review of one's own operation on aspects that may have on quality effect on quality assurance. In general, self-inspection aims at identifying defects whether of critical, major or minor nature.

Continue ReadingSelf Inspection

Blotting Technique Notes pdf

Blotting is the technique in which nucleic acids or proteins are immobilized onto a solid support generally nylon or nitrocellulose membranes. Blotting of nucleic acid is the central technique for hybridization studies. Nucleic acid labeling and hybridization on membranes have formed the basis for a range of experimental techniques involving understanding of gene expression, organization, etc.

Continue ReadingBlotting Technique Notes pdf